Yes, as I remember it, the risk was tangible. Someone mentioned the devaluation of Air Transat to this committee. In your case, we're talking about emerging businesses that have specific expertise; so there was an enormous patent risk.
Since I don't have much time, I'll get right down to your board's deliberations. I have training as a certified corporate director, a CBD, and I like the way you talk about declaring real, apparent and potential conflicts of interest and about withdrawing or recusing yourself as necessary.
Would you please tell us more about your board? How many directors at the table were in conflict of interest when the board voted on that emergency measure during the pandemic?